Testing Different Combinations of Acoustic Pressure and Doses of Quinolinic Acid for Induction of Focal Neuron Loss...

Area of Science:

• Neuroscience
• Biomedical Engineering
• Pharmacology

Background:

• Developing precise methods for creating focal neuronal lesions is crucial for studying brain function and treating neurological disorders.
• Magnetic resonance-guided focused ultrasound (MRgFUS) offers a non-invasive approach for targeted tissue ablation.
• Quinolinic acid (QA) is an excitotoxin that can induce neuronal damage.

Purpose of the Study:

• To investigate the optimal combination of acoustic pressure and quinolinic acid dosage for inducing focal hippocampal lesions in mice.
• To determine the threshold of acoustic pressure and QA dose required for effective neuronal loss without collateral damage.
• To evaluate the dose-dependent effects of QA and acoustic pressure on lesion size and integrity.

Main Methods:

• Sixty male CD-1 mice were divided into 12 experimental groups.
• MRgFUS was applied at high (0.67 MPa), medium (0.5 MPa), and low (0.33 MPa) acoustic peak negative pressures.
• Mice received varying doses of quinolinic acid: high (0.012 mmol), medium (0.006 mmol), and low (0.003 mmol).

Main Results:

• Neuronal loss was observed exclusively when MRgFUS (0.67 or 0.5 MPa) was combined with QA.
• Higher acoustic pressures (0.67 MPa) produced larger lesions compared to medium pressures (0.5 MPa), though two mice experienced bleeding.
• At intermediate acoustic power (0.5 MPa), higher QA dosages (medium and high) resulted in significantly larger lesions than the low dosage.

Conclusions:

• The combination of MRgFUS and quinolinic acid is a viable method for creating focal neuronal lesions in the murine hippocampus.
• Acoustic pressure and QA dosage are critical parameters influencing lesion size and efficacy.
• Careful titration of acoustic power is necessary to avoid unintended tissue damage such as hemorrhage.